_id
69148f74ccc777a4e85d9be1
Ticker
POM
Name
POMDOCTOR LIMITED American Depositary Shares
Exchange
NASDAQ
Address
Yongxu Industrial Park, Guangzhou, China, 510000
Country
USA
Sector
Healthcare
Industry
Pharmaceutical Retailers
Currency
USD
Website
https://www.7lk.com
Description
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company's business primarily consists of internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.
Last Close
0.31
Volume
582020
Current Price
0.318
Change
-0.0008
Last Updated
2026-01-06T09:25:58.115Z
Image
-
Ipo Date
2025-10-08T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2020-03-31
Revenue
8747000000
Cost Of Revenue
3867000000
Gross Profit
4880000000
Operating Expenses
38000000
Operating Income
1220000000
Interest Expense
-
Pretax Income
85000000
Net Income
45000000
Eps
0.04610655737704918
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-294000000
EBITDA
1129000000
Operating Margin
13.947639190579627
Total Other Income Expense Net
-1135000000
Cash
1457000000
Short Term Investments
656000000
Receivables
4042000000
Inventories
161000000
Total Current Assets
12476000000
Property Plant Equipment
81017000000
Total Assets
124677000000
Payables
2883000000
Short Term Debt
2848000000
Long Term Debt
-
Total Liabilities
92195000000
Equity
32482000000
Bs_currency_symbol
-
Depreciation
1378000000
Change In Working Capital
710000000
Cash From Operations
1080000000
Capital Expenditures
2016000000
Cash From Investing
-2075000000
Cash From Financing
1865000000
Net Change In Cash
870000000
Cf_currency_symbol
-
PE
-
PB
0.009555076657841267
ROE
0.1385382673480697
ROA
0.036093264996751605
FCF
-936000000
Fcf Percent
-0.10700811706870927
Piotroski FScore
4
Health Score
37
Deep Value Investing Score
6
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
1
Growth Investing Score
1.5
Momentum Investing Score
8
Net Net Investing Score
2
Quality Investing Score
2
Value Investing Score
6.5
Quarters > 0 > quarter
2020-03-31
Quarters > 0 > income Statement > revenue
8747000000
Quarters > 0 > income Statement > cost Of Revenue
3867000000
Quarters > 0 > income Statement > gross Profit
4880000000
Quarters > 0 > income Statement > operating Expenses
38000000
Quarters > 0 > income Statement > operating Income
1220000000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
85000000
Quarters > 0 > income Statement > net Income
45000000
Quarters > 0 > income Statement > eps
0.04610655737704918
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
976000000
Quarters > 0 > income Statement > income Tax Expense
-294000000
Quarters > 0 > income Statement > EBITDA
1129000000
Quarters > 0 > income Statement > operating Margin
13.947639190579627
Quarters > 0 > income Statement > total Other Income Expense Net
-1135000000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
1457000000
Quarters > 0 > balance Sheet > short Term Investments
656000000
Quarters > 0 > balance Sheet > receivables
4042000000
Quarters > 0 > balance Sheet > inventories
161000000
Quarters > 0 > balance Sheet > total Current Assets
12476000000
Quarters > 0 > balance Sheet > property Plant Equipment
81017000000
Quarters > 0 > balance Sheet > total Assets
124677000000
Quarters > 0 > balance Sheet > payables
2883000000
Quarters > 0 > balance Sheet > short Term Debt
2848000000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
92195000000
Quarters > 0 > balance Sheet > equity
32482000000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
45000000
Quarters > 0 > cash Flow > depreciation
1378000000
Quarters > 0 > cash Flow > change In Working Capital
710000000
Quarters > 0 > cash Flow > cash From Operations
1080000000
Quarters > 0 > cash Flow > capital Expenditures
2016000000
Quarters > 0 > cash Flow > cash From Investing
-2075000000
Quarters > 0 > cash Flow > cash From Financing
1865000000
Quarters > 0 > cash Flow > net Change In Cash
870000000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.04610655737704918
Quarters > 0 > ratios > PB
0.009555076657841267
Quarters > 0 > ratios > ROE
0.1385382673480697
Quarters > 0 > ratios > ROA
0.036093264996751605
Quarters > 0 > ratios > FCF
-936000000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
-0.10700811706870927
Quarters > 0 > health Score
37
Quarters > 1 > quarter
2019-12-31
Quarters > 1 > income Statement > revenue
8342000000
Quarters > 1 > income Statement > cost Of Revenue
3766000000
Quarters > 1 > income Statement > gross Profit
4576000000
Quarters > 1 > income Statement > operating Expenses
7393000000
Quarters > 1 > income Statement > operating Income
962000000
Quarters > 1 > income Statement > interest Expense
389000000
Quarters > 1 > income Statement > pretax Income
957000000
Quarters > 1 > income Statement > net Income
808000000
Quarters > 1 > income Statement > eps
0.8295687885010267
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
974000000
Quarters > 1 > income Statement > income Tax Expense
384000000
Quarters > 1 > income Statement > EBITDA
932000000
Quarters > 1 > income Statement > operating Margin
11.532006713018461
Quarters > 1 > income Statement > total Other Income Expense Net
-5000000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
163000000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
723000000
Quarters > 1 > balance Sheet > property Plant Equipment
6022000000
Quarters > 1 > balance Sheet > total Assets
6745000000
Quarters > 1 > balance Sheet > payables
106000000
Quarters > 1 > balance Sheet > short Term Debt
130000000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
3476000000
Quarters > 1 > balance Sheet > equity
10677000000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
808000000
Quarters > 1 > cash Flow > depreciation
-265000000
Quarters > 1 > cash Flow > change In Working Capital
871000000
Quarters > 1 > cash Flow > cash From Operations
-95000000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-17000000
Quarters > 1 > cash Flow > cash From Financing
2000000
Quarters > 1 > cash Flow > net Change In Cash
-346000000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.8295687885010267
Quarters > 1 > ratios > PB
0.02900927226749087
Quarters > 1 > ratios > ROE
7.567668820829822
Quarters > 1 > ratios > ROA
11.979243884358784
Quarters > 1 > ratios > FCF
-95000000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.011388156317429872
Quarters > 1 > health Score
64
Quarters > 2 > quarter
2019-09-30
Quarters > 2 > income Statement > revenue
16619000000
Quarters > 2 > income Statement > cost Of Revenue
3953000000
Quarters > 2 > income Statement > gross Profit
12666000000
Quarters > 2 > income Statement > operating Expenses
7561000000
Quarters > 2 > income Statement > operating Income
2194000000
Quarters > 2 > income Statement > interest Expense
805000000
Quarters > 2 > income Statement > pretax Income
1746000000
Quarters > 2 > income Statement > net Income
365000000
Quarters > 2 > income Statement > eps
0.3751284686536485
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
973000000
Quarters > 2 > income Statement > income Tax Expense
316000000
Quarters > 2 > income Statement > EBITDA
4419000000
Quarters > 2 > income Statement > operating Margin
13.201757025091762
Quarters > 2 > income Statement > total Other Income Expense Net
-448000000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
1683000000
Quarters > 2 > balance Sheet > short Term Investments
601000000
Quarters > 2 > balance Sheet > receivables
4188000000
Quarters > 2 > balance Sheet > inventories
162000000
Quarters > 2 > balance Sheet > total Current Assets
12206000000
Quarters > 2 > balance Sheet > property Plant Equipment
78593000000
Quarters > 2 > balance Sheet > total Assets
122738000000
Quarters > 2 > balance Sheet > payables
3348000000
Quarters > 2 > balance Sheet > short Term Debt
4248000000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
90715000000
Quarters > 2 > balance Sheet > equity
32023000000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
365000000
Quarters > 2 > cash Flow > depreciation
2933000000
Quarters > 2 > cash Flow > change In Working Capital
10509000000
Quarters > 2 > cash Flow > cash From Operations
4355000000
Quarters > 2 > cash Flow > capital Expenditures
3386000000
Quarters > 2 > cash Flow > cash From Investing
-3429000000
Quarters > 2 > cash Flow > cash From Financing
-62000000
Quarters > 2 > cash Flow > net Change In Cash
864000000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.3751284686536485
Quarters > 2 > ratios > PB
0.009662242763014084
Quarters > 2 > ratios > ROE
1.1398057646066888
Quarters > 2 > ratios > ROA
0.2973814140689925
Quarters > 2 > ratios > FCF
969000000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.058306757325952224
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2019-06-30
Quarters > 3 > income Statement > revenue
7689000000
Quarters > 3 > income Statement > cost Of Revenue
3225000000
Quarters > 3 > income Statement > gross Profit
4464000000
Quarters > 3 > income Statement > operating Expenses
6880000000
Quarters > 3 > income Statement > operating Income
842000000
Quarters > 3 > income Statement > interest Expense
403000000
Quarters > 3 > income Statement > pretax Income
644000000
Quarters > 3 > income Statement > net Income
494000000
Quarters > 3 > income Statement > eps
0.5079691516709511
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
972500000
Quarters > 3 > income Statement > income Tax Expense
205000000
Quarters > 3 > income Statement > EBITDA
1154000000
Quarters > 3 > income Statement > operating Margin
10.950708804786057
Quarters > 3 > income Statement > total Other Income Expense Net
-198000000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
54000000
Quarters > 3 > balance Sheet > short Term Investments
133000000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1546000000
Quarters > 3 > balance Sheet > property Plant Equipment
13788000000
Quarters > 3 > balance Sheet > total Assets
19339000000
Quarters > 3 > balance Sheet > payables
3248000000
Quarters > 3 > balance Sheet > short Term Debt
1059000000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
87689000000
Quarters > 3 > balance Sheet > equity
31548000000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
494000000
Quarters > 3 > cash Flow > depreciation
257000000
Quarters > 3 > cash Flow > change In Working Capital
-11635000000
Quarters > 3 > cash Flow > cash From Operations
31000000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
6000000
Quarters > 3 > cash Flow > cash From Financing
-1000000
Quarters > 3 > cash Flow > net Change In Cash
38000000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.5079691516709511
Quarters > 3 > ratios > PB
0.009802681627995436
Quarters > 3 > ratios > ROE
1.5658678838595157
Quarters > 3 > ratios > ROA
2.5544237033972803
Quarters > 3 > ratios > FCF
31000000
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
0.004031733645467551
Quarters > 3 > health Score
37
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
342557920
Annuals > 0 > income Statement > cost Of Revenue
294863867
Annuals > 0 > income Statement > gross Profit
47694053
Annuals > 0 > income Statement > operating Expenses
73485333
Annuals > 0 > income Statement > operating Income
-25791280
Annuals > 0 > income Statement > interest Expense
12964584
Annuals > 0 > income Statement > pretax Income
-37365434
Annuals > 0 > income Statement > net Income
-143360926
Annuals > 0 > income Statement > eps
-1.2103631099646956
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
118444560
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-24266340
Annuals > 0 > income Statement > operating Margin
-7.529027499933442
Annuals > 0 > income Statement > total Other Income Expense Net
-11574154
Annuals > 0 > income Statement > currency_symbol
CNY
Annuals > 0 > balance Sheet > cash
7651695
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
14973746
Annuals > 0 > balance Sheet > inventories
9165973
Annuals > 0 > balance Sheet > total Current Assets
37497413
Annuals > 0 > balance Sheet > property Plant Equipment
461362
Annuals > 0 > balance Sheet > total Assets
46227586
Annuals > 0 > balance Sheet > payables
25346377
Annuals > 0 > balance Sheet > short Term Debt
74340766
Annuals > 0 > balance Sheet > long Term Debt
365090859
Annuals > 0 > balance Sheet > total Liabilities
2140960106
Annuals > 0 > balance Sheet > equity
-2263421920
Annuals > 0 > balance Sheet > currency_symbol
CNY
Annuals > 0 > cash Flow > net Income
-37365434
Annuals > 0 > cash Flow > depreciation
134510
Annuals > 0 > cash Flow > change In Working Capital
17529270
Annuals > 0 > cash Flow > cash From Operations
-16130880
Annuals > 0 > cash Flow > capital Expenditures
37773
Annuals > 0 > cash Flow > cash From Investing
-33373
Annuals > 0 > cash Flow > cash From Financing
17016080
Annuals > 0 > cash Flow > net Change In Cash
846596
Annuals > 0 > cash Flow > currency_symbol
CNY
Annuals > 0 > ratios > PE
-1.2103631099646956
Annuals > 0 > ratios > PB
-0.017012438607115727
Annuals > 0 > ratios > ROE
6.33381362675855
Annuals > 0 > ratios > ROA
-310.1198621965681
Annuals > 0 > ratios > FCF
-16168653
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.04719976405741838
Annuals > 0 > health Score
20
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
304852971
Annuals > 1 > income Statement > cost Of Revenue
266131202
Annuals > 1 > income Statement > gross Profit
38721769
Annuals > 1 > income Statement > operating Expenses
60970671
Annuals > 1 > income Statement > operating Income
-22248902
Annuals > 1 > income Statement > interest Expense
13849119
Annuals > 1 > income Statement > pretax Income
-36949421
Annuals > 1 > income Statement > net Income
-145390832
Annuals > 1 > income Statement > eps
-1.22750113639664
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
118444560
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-22988210
Annuals > 1 > income Statement > operating Margin
-7.29824017362127
Annuals > 1 > income Statement > total Other Income Expense Net
-14700519
Annuals > 1 > income Statement > currency_symbol
CNY
Annuals > 1 > balance Sheet > cash
6717031
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
32388228
Annuals > 1 > balance Sheet > inventories
12694419
Annuals > 1 > balance Sheet > total Current Assets
59417510
Annuals > 1 > balance Sheet > property Plant Equipment
595872
Annuals > 1 > balance Sheet > total Assets
66307497
Annuals > 1 > balance Sheet > payables
41689098
Annuals > 1 > balance Sheet > short Term Debt
56674229
Annuals > 1 > balance Sheet > long Term Debt
355403827
Annuals > 1 > balance Sheet > total Liabilities
2027727136
Annuals > 1 > balance Sheet > equity
-2120055763
Annuals > 1 > balance Sheet > currency_symbol
CNY
Annuals > 1 > cash Flow > net Income
-36949421
Annuals > 1 > cash Flow > depreciation
112092
Annuals > 1 > cash Flow > change In Working Capital
-12556918
Annuals > 1 > cash Flow > cash From Operations
-45795682
Annuals > 1 > cash Flow > capital Expenditures
111891
Annuals > 1 > cash Flow > cash From Investing
-111891
Annuals > 1 > cash Flow > cash From Financing
50067178
Annuals > 1 > cash Flow > net Change In Cash
4159605
Annuals > 1 > cash Flow > currency_symbol
CNY
Annuals > 1 > ratios > PE
-1.22750113639664
Annuals > 1 > ratios > PB
-0.018162883792033537
Annuals > 1 > ratios > ROE
6.857877728379355
Annuals > 1 > ratios > ROA
-219.26756185654241
Annuals > 1 > ratios > FCF
-45907573
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.15058922617486972
Annuals > 1 > health Score
21
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
245216716
Annuals > 2 > income Statement > cost Of Revenue
190355421
Annuals > 2 > income Statement > gross Profit
54861295
Annuals > 2 > income Statement > operating Expenses
58455574
Annuals > 2 > income Statement > operating Income
-3594279
Annuals > 2 > income Statement > interest Expense
16023365
Annuals > 2 > income Statement > pretax Income
-19832028
Annuals > 2 > income Statement > net Income
-125510228
Annuals > 2 > income Statement > eps
-1.0596537992120534
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
118444560
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-3808663
Annuals > 2 > income Statement > operating Margin
-1.4657561110148787
Annuals > 2 > income Statement > total Other Income Expense Net
-16237749
Annuals > 2 > income Statement > currency_symbol
CNY
Annuals > 2 > balance Sheet > cash
2485598
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
27253251
Annuals > 2 > balance Sheet > inventories
8195532
Annuals > 2 > balance Sheet > total Current Assets
47740066
Annuals > 2 > balance Sheet > property Plant Equipment
0
Annuals > 2 > balance Sheet > total Assets
48617692
Annuals > 2 > balance Sheet > payables
43347224
Annuals > 2 > balance Sheet > short Term Debt
30870862
Annuals > 2 > balance Sheet > long Term Debt
318927879
Annuals > 2 > balance Sheet > total Liabilities
1946620159
Annuals > 2 > balance Sheet > equity
-1974664931
Annuals > 2 > balance Sheet > currency_symbol
CNY
Annuals > 2 > cash Flow > net Income
-19832028
Annuals > 2 > cash Flow > depreciation
0
Annuals > 2 > cash Flow > change In Working Capital
-1410826
Annuals > 2 > cash Flow > cash From Operations
-22017303
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
22491967
Annuals > 2 > cash Flow > net Change In Cash
474664
Annuals > 2 > cash Flow > currency_symbol
CNY
Annuals > 2 > ratios > PE
-1.0596537992120534
Annuals > 2 > ratios > PB
-0.01950018246209488
Annuals > 2 > ratios > ROE
6.356026586061855
Annuals > 2 > ratios > ROA
-258.15752010605524
Annuals > 2 > ratios > FCF
-22017303
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-0.08978712120098696
Annuals > 2 > health Score
20
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
215384670
Annuals > 3 > income Statement > cost Of Revenue
162877305
Annuals > 3 > income Statement > gross Profit
52507365
Annuals > 3 > income Statement > operating Expenses
132175374
Annuals > 3 > income Statement > operating Income
-79668009
Annuals > 3 > income Statement > interest Expense
16290371
Annuals > 3 > income Statement > pretax Income
-96181846
Annuals > 3 > income Statement > net Income
-188402525
Annuals > 3 > income Statement > eps
-1.5906389031290251
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
118444560
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-58575288
Annuals > 3 > income Statement > operating Margin
-36.98870908500591
Annuals > 3 > income Statement > total Other Income Expense Net
-16513837
Annuals > 3 > income Statement > currency_symbol
CNY
Annuals > 3 > balance Sheet > cash
2170830
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
739569
Annuals > 3 > balance Sheet > inventories
8117969
Annuals > 3 > balance Sheet > total Current Assets
18433630
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
19311256
Annuals > 3 > balance Sheet > payables
30405714
Annuals > 3 > balance Sheet > short Term Debt
25808754
Annuals > 3 > balance Sheet > long Term Debt
312505393
Annuals > 3 > balance Sheet > total Liabilities
1796801616
Annuals > 3 > balance Sheet > equity
-1849154703
Annuals > 3 > balance Sheet > currency_symbol
CNY
Annuals > 3 > cash Flow > net Income
-96181846
Annuals > 3 > cash Flow > depreciation
21316187
Annuals > 3 > cash Flow > change In Working Capital
35138445
Annuals > 3 > cash Flow > cash From Operations
-15681431
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-500000
Annuals > 3 > cash Flow > cash From Financing
5436861
Annuals > 3 > cash Flow > net Change In Cash
-10744570
Annuals > 3 > cash Flow > currency_symbol
CNY
Annuals > 3 > ratios > PE
-1.5906389031290251
Annuals > 3 > ratios > PB
-0.020823745246154237
Annuals > 3 > ratios > ROE
10.188575606699793
Annuals > 3 > ratios > ROA
-975.6098981858041
Annuals > 3 > ratios > FCF
-15681431
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.0728066254668914
Annuals > 3 > health Score
22
Valuation > metrics > PE
0.04610655737704918
Valuation > metrics > PB
0.009555076657841267
Valuation > final Score
90
Valuation > verdict
99.3% Undervalued
Profitability > metrics > ROE
0.1385382673480697
Profitability > metrics > ROA
0.3606925296569413
Profitability > metrics > Net Margin
0.005144621012918715
Profitability > final Score
2
Profitability > verdict
Weak
Risk > metrics > Debt Equity
2.838341235145619
Risk > metrics > Interest Coverage
1.1685823754789273
Risk > final Score
23
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.176932472517885
Liquidity > metrics > Quick Ratio
2.1488396440411797
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
90
Prev Valuations > 2
90
Prev Profitabilities > 0
60
Prev Profitabilities > 1
15
Prev Profitabilities > 2
43
Prev Risks > 0
70
Prev Risks > 1
29
Prev Risks > 2
26
Prev Liquidities > 0
100
Prev Liquidities > 1
90
Prev Liquidities > 2
28
Updated At
2026-01-20T22:24:48.466Z
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company's business primarily consists of internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APomdoctor Deepens Pharma Partnerships to Drive Internet Hospital Expansion in China - TipRanks
1/16/2026
Pomdoctor Deepens Pharma Partnerships to Drive Internet Hospital Expansion in China TipRanks
Read more →China's online drug boom backs Pomdoctor's new online path to meds Stock Titan
Read more →Showing 2 of 10
(Last Updated 2020-03-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of POMDOCTOR LIMITED American Depositary Shares
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2020-03-31)
(Last Updated 2020-03-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2020-03-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2020-03-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.